Skip to main content
. 2022 Jul 6;6(13):3911–3920. doi: 10.1182/bloodadvances.2021006520

Table 1.

Baseline patient characteristics

Characteristic Total N= 25
n (%)
Median age, y (range): 55 (30-78)
Sex Male 13 (52)
ECOG 0 21 (84)
1 3 (12)
2 1 (4)
Ann Arbor Stage II 2 (8)
III/IV 23 (92)
FL grade 1 or 2 19 (76)
3a 6 (24)
FLIPI Low risk (0-1) 5 (20)
Intermediate risk (2) 8 (32)
High risk (3-5) 12 (48)
Reason for treatment start (>1 possible) B-symptoms 10 (40)
Bulky disease (≥6 cm) 11 (44)
Progression in the last 6 mo 13 (52)
Symptomatic disease 20 (80)